Choledocholithiasis

Last revised by Calum Worsley on 19 Feb 2023

Choledocholithiasis denotes the presence of gallstones within the bile ducts (including the common hepatic duct/common bile duct).

Choledocholithiasis is relatively common, seen in up to 20% of patients undergoing cholecystectomy for gallstone-related complaints 2.

Stones within the bile ducts are occasionally asymptomatic and may be found incidentally. However, more frequently they lead to symptomatic presentation with:

Stones within the bile duct most commonly pass from the gallbladder but may form in situ. When recurrent, they tend to be pigment stones, and are thought to be associated with bacterial infection 1.

Although ultrasound is usually the first investigation for biliary disease, it has average sensitivity for the detection of biliary stones within the bile duct.

Ultrasound should be performed both longitudinally and transversely through the duct with particular attention paid to the very distal portion of the common bile duct as it passes through the pancreatic head (best assessed transversely).

Findings include:

  • visualization of stone(s)

    • echogenic rounded focus

    • size ranges between 2 to >20 mm

    • shadowing may be more difficult to elicit than with gallstones within the gallbladder

    • ~20% of common bile duct stones will not shadow

    • twinkling artifact may be useful to detect occult stones

  • dilated bile duct

    • >6 mm + 1 mm per decade above 60 years of age

    • >10 mm post-cholecystectomy

    • dilated intrahepatic biliary tree

  • gallstones should increase suspicion, especially if multiple and small

Recently endoscopic ultrasonography (EUS) has also been used with very high sensitivity and specificity.

Routine contrast-enhanced CT is moderately sensitive to choledocholithiasis with a sensitivity of 65-88% 3, but it requires attention to a number of potentially subtle findings. These include:

  • target sign

    • central rounded density: stone

    • surrounding lower attenuating bile or mucosa

  • rim sign: stone is outlined by thin shell of density

  • crescent sign: bile eccentrically outlines luminal stone, creating a low attenuation crescent

  • calcification of the stone: unfortunately only 20% of stones are of high density

Setting window level to the mean of the bile duct and setting the window width to 150 HU has been reported to improve sensitivity.

Biliary dilatation may also be visible.

CT with prior administration of biliary excreted contrast agents is highly sensitive (88-96%) and specific (88-98%) 8 for choledocholithiasis. The difficulty is, however, two-fold:

  1. contrast agents have relatively high complication rates

  2. obstructive cholestasis diminishes excretion, and thus is only viable in patients with largely normal liver function tests

Magnetic resonance cholangiopancreatography (MRCP) has largely replaced ERCP as the gold standard for diagnosis of choledocholithiasis, able to achieve similar sensitivity (90-94%) and specificity (95-99%) 7,8 without ionizing radiation, intravenous contrast, or the complication rate inherent in ERCP.

Filling defects are seen within the biliary tree on thin cross-sectional T2 weighted imaging. Care should be taken not to use thick slabs for the diagnosis as volume averaging may obscure smaller stones.

However, if the diagnosis has already been secured by ultrasound or CT, there is no additional value of MRCP, and the next step is therapeutic ERCP (see below).

Both investigations are no longer used for routine diagnosis having been replaced by ultrasound, CT and MRCP.

Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is the treatment of choice for choledocholithiasis, however, is associated with a complication rate of 5.8-24% (10 years follow-up) 1.

Complications of ERCP and sphincterotomy include:

Failure of endoscopic clearance of bile duct stones may require either intraoperative bile duct exploration, or percutaneous biliary drainage to decompress the biliary system to temporise and allow subsequent definitive management.

There is usually little differential, and differential will depend on the modality. The most frequent entities to consider include:

ADVERTISEMENT: Supporters see fewer/no ads

Cases and figures

  • Case 1: MRCP
    Drag here to reorder.
  • Case 2: T-tube cholangiogram
    Drag here to reorder.
  • Case 3: multiple tiny calculi
    Drag here to reorder.
  • Case 4: ERCP and ultrasound
    Drag here to reorder.
  • Case 5: MRCP and CT
    Drag here to reorder.
  • Case 6: ultrasound
    Drag here to reorder.
  • Case 7: labeled MRCP
    Drag here to reorder.
  • Case 8: labeled CT
    Drag here to reorder.
  • Case 9: MRCP
    Drag here to reorder.
  • Case 10: ultrasound
    Drag here to reorder.
  • Case 11: MRCP and CT
    Drag here to reorder.
  • Case 12: CT
    Drag here to reorder.
  • Case 13: MRCP
    Drag here to reorder.
  • Case 14: CT
    Drag here to reorder.
  • Case 15: MRCP
    Drag here to reorder.
  • Case 16: cholangiogram
    Drag here to reorder.
  • Case 17: MRCP
    Drag here to reorder.
  • Case 18: CT
    Drag here to reorder.
  • Case 19: MRCP
    Drag here to reorder.
  • Case 20: cholangiogram
    Drag here to reorder.
  • Case 21: MRCP
    Drag here to reorder.
  • Case 22: CT
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.